July 2022 - VIPOC

Vitiligo research

FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease.

By Becky Upham July 22, 2022 On July 18, the U.S. Food and Drug Administration…

Thando Ngwenya27 July 2022

© 2022 VIPOC. Copyright © VIPOC Built by Simboti Digital All rights reserved.|Privacy Policy - English|Privacy Policy - French